TORONTO, Canada, Nov. 13, 2003 (PRIMEZONE) -- BacTech Enviromet Corporation ("BacTech") (TSX Venture Exchange:YBA) today announced that the Golden Arrow Fund, a subsidiary of Rothschild Australia and a significant shareholder in BacTech, has exercised 1,180,000 common share purchase warrants at $0.45 per share. The proceeds will be added to working capital. BacTech has now raised $7.53 million in new equity since June of this year.
CORPORATE PROFILE
On August 5, 2003, BacTech announced the closing of its acquisition of a 55% interest in the Tonkin Springs Gold Project located in north-central Nevada, USA, on the prolific Cortez Trend.
BacTech has developed and patented bioleach technology for the treatment of refractory ores and concentrates to enhance the recovery of gold, silver and base metals. BacTech has commissioned three commercial bioleach plants for the recovery of gold and more recently has successfully demonstrated its technology in the selective recovery of precious and base metals from complex sulphide concentrates. Bioleaching is a commercially accepted and environmentally friendly alternative to conventional smelting operations and provides BacTech with a distinct market advantage in the acquisition and operation of mineral properties. BacTech's business is to own and operate mining projects independently or in joint venture.